AORT Artivion, Inc.: Utang jangka cendhak perusahaan

Artivion, Inc. is implementing environmental standards by reducing energy costs and production waste. The development of cardiac surgery technologies relies on strategic alliances and the acquisition of bioprosthetic solutions. Stable demand for durable tissue valves confirms the business's maturity. Total short-term debt on this chart demonstrates the financial burden, where the current metric equals 0.00, characterizing the issuer's operational transparency.

This indicator tracks the volume of liabilities with a maturity of up to one year, reflecting the liquidity and ability of the issuer to cover operational gaps. The trend of total short-term liabilities is critical for Artivion, Inc. (AORT), as intensive R&D expenditures for cardiac surgery prostheses and stents require strict control over borrowed capital to prevent funding shortages.